Brief: H.U. Group Holdings Subsidiary Fujirebio Has Received Production, Sales Approval For Coronavirus, Influenza Simultaneous Test Kit Espline Sars-Cov-2&Flu A+B From Japan's Health Ministry
05/12/2022 11:42
Dec 5 (Reuters) - H.U. Group Holdings Inc 4544.T :
* SUBSIDIARY FUJIREBIO HAS RECEIVED PRODUCTION, SALES
APPROVAL FOR
CORONAVIRUS, INFLUENZA SIMULTANEOUS TEST KIT ESPLINE
SARS-COV-2&FLU A+B FROM JAPAN'S HEALTH MINISTRY
Further company coverage: 4544.T